| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 02/17/2005 | US20050035267 Furnace mount and method of installation |
| 02/17/2005 | US20050035266 Furnace Mount and Method of Installation |
| 02/17/2005 | DE10335450A1 New N-(4-(indoline-1-sulfonyl)-phenyl)-amino acid derivatives, are peroxisome proliferator activated receptor delta activators used e.g. for treating or preventing stroke, arteriosclerosis, coronary heart disease and dyslipidemia |
| 02/17/2005 | DE10335027A1 Use of telmisartan and simvastatin for treatment or prophylaxis of cardiovascular, cardiopulmonary and renal diseases e.g. hypertension combined with hyperlipidemia or atherosclerosis |
| 02/17/2005 | DE10332685A1 Use of a modulator of specific potassium channels, expressed preferentially in the atrium, for treatment and prevention of arrhythmia, coronary disease and hypertension |
| 02/17/2005 | CA2535446A1 Methods for preventing neurological events |
| 02/17/2005 | CA2535125A1 Pyridylpyrrole derivatives active as kinase inhibitors |
| 02/17/2005 | CA2535066A1 Macrophage activation inhibitor |
| 02/17/2005 | CA2534971A1 5'-and 3'-capped aptamers and uses therefor |
| 02/17/2005 | CA2534869A1 A pharmaceutical composition comprising an extract from trichilia sp. and its use for treating and preventing ventricular fibrillation |
| 02/17/2005 | CA2534496A1 Pyrimidylpyrrole derivatives active as kinase inhibitors |
| 02/17/2005 | CA2534471A1 Method and apparatus for producing ultrafine drug particles |
| 02/17/2005 | CA2534422A1 Quinazoline derivatives as inhibitors of vegf receptor tyrosine kinases |
| 02/17/2005 | CA2534415A1 Therapeutic delivery of carbon monoxide |
| 02/17/2005 | CA2533432A1 Novel derivatives of 4,4'-dithiobis-(3-aminobutane-1-sulfonates) and compositions comprising the same |
| 02/17/2005 | CA2532444A1 Compositions containing macrophages and uses thereof |
| 02/16/2005 | EP1506999A1 Dedifferentiated, programmable stem cells of monocytic origin, and their production and use |
| 02/16/2005 | EP1506962A2 Nitrogen-containing aromatic heterocycles |
| 02/16/2005 | EP1506951A1 Preparation and application of transhintotalphenolic acid |
| 02/16/2005 | EP1506779A1 (3-(4-(Pyridin-2-ylamino)-butyryl)-2,3,4,4a,9,9a-hexahydro-1H-3-aza-fluoren-9-yl)-acetic acid derivatives and related tricyclic indanyls as alphaVbeta3 and alphaVbeta5 integrin inhibitors for the treatment of cancer and unstable angina |
| 02/16/2005 | EP1506409A1 Assays for modulators of asparaginyl hydroxylase |
| 02/16/2005 | EP1506286A2 Neutralizing human anti-igfr antibody |
| 02/16/2005 | EP1506285A2 Combinations of antibodies selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and other therapeutic agents |
| 02/16/2005 | EP1506214A1 6-11 bicyclic ketolide derivatives |
| 02/16/2005 | EP1506211A1 C-aryl glucoside sglt2 inhibitors and method |
| 02/16/2005 | EP1506205A2 Novel azacyclic ethynyl derivatives |
| 02/16/2005 | EP1506200A2 Novel diazabicyclic biaryl derivatives |
| 02/16/2005 | EP1506193A1 Carbamate-substituted pyrazolopyridines |
| 02/16/2005 | EP1506192A1 Substituted pyrroline kinase inhibitors |
| 02/16/2005 | EP1506191A1 Benzoxazine and benzoxazinone substituted triazoles |
| 02/16/2005 | EP1506187A1 2-thio-substituted imidazole derivatives and their use in pharmaceutics |
| 02/16/2005 | EP1506186A1 Substituted heterocyclic compounds and methods of use |
| 02/16/2005 | EP1506176A1 Aminoindazole derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them |
| 02/16/2005 | EP1506174A2 Opioid and opioid-like compounds and uses thereof |
| 02/16/2005 | EP1506040A2 Selective inos inhibitors for the treatment of respiratory diseases and conditions |
| 02/16/2005 | EP1506015A2 Pharmaceutical combination of pde5 inhibitors with ace inhibitors |
| 02/16/2005 | EP1506011A2 An antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and uses thereof |
| 02/16/2005 | EP1505994A1 Novel use of the extract of processed ginseng and saponin isolated therefrom |
| 02/16/2005 | EP1505986A1 COMBINATION OF AN HMG-CoA REDUCTASE INHIBITOR AND A NITRATE ESTER |
| 02/16/2005 | EP1505984A2 Nutritional supplements and methods for prevention, reduction and treatment of radiation injury |
| 02/16/2005 | EP1505983A2 Aldosterone blocker therapy to prevent or treat inflammation-related disorders |
| 02/16/2005 | EP1505982A1 Trimegestone and estrogens for treating post menopausal disorders |
| 02/16/2005 | EP1505979A1 Phenyl substituted imidazopyridines and phenyl substituted benzimidazoles |
| 02/16/2005 | EP1505973A2 Methods and compositions using immunomodulatory compounds for treatment and management of cancers and other diseases |
| 02/16/2005 | EP1505968A1 Multicyclic compounds for use as melanin concentrating hormone antagonists in the treatment of obesity and diabetes |
| 02/16/2005 | EP1505967A1 Method for treating obesity |
| 02/16/2005 | EP1505965A1 Use of valsartan ot its metabolite to inhibit platelet aggregation |
| 02/16/2005 | EP1505959A1 Use of edg receptor binding agents in cancer |
| 02/16/2005 | EP1505930A2 Drug-delivery endovascular stent and method for treating restenosis |
| 02/16/2005 | EP1425258A4 Hydroxyeicosenoic acid analogs |
| 02/16/2005 | EP1397365B1 Heteroaryl-diazabicyclo-alkanes as cns-modulators |
| 02/16/2005 | EP1395553B1 Pyrrolidine derivatives as factor xa inhibitors |
| 02/16/2005 | EP1339675B1 Ortho-substituted and meta-substituted bis-aryl compounds, method for the production thereof, their use as a medicament, and pharmaceutical preparations containing these compounds |
| 02/16/2005 | EP1296698A4 Therapeutic agents - ii |
| 02/16/2005 | EP1296697A4 Therapeutic agents - i |
| 02/16/2005 | EP1294741B1 Dipeptide inhibitors for the blood-clotting factor xa |
| 02/16/2005 | EP1281709B1 Novel heterocyclic compounds with anti-inflammatory activity |
| 02/16/2005 | EP1268463B1 Polycyclic aryl and heteroaryl substituted 4-pyrones useful for selective inhibition of the coagulation cascade |
| 02/16/2005 | EP1253917B1 Use of substituted 4-amino-1-phenylbutan-2-ol compounds as medicaments |
| 02/16/2005 | EP1246814B1 Compounds and methods for modulation of estrogen receptors |
| 02/16/2005 | EP1197223B1 Preventives / remedies / progression inhibitors for simplex retinopathy or preproliferating retinopathy |
| 02/16/2005 | EP1037906B1 Cyclopeptide derivatives with integrin inhibitor properties |
| 02/16/2005 | EP0986540B1 The use of carbocyclic and heterocyclic substituted semicarbazones and thiosemicarbazones as sodium channel blockers |
| 02/16/2005 | CN1582301A Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells |
| 02/16/2005 | CN1582287A Thiophenylthiopyrane dioxides as MMP or TNF-alpha inhibitors |
| 02/16/2005 | CN1582283A Benzothiepine ileal bile acid transport inhibitors |
| 02/16/2005 | CN1582282A Novel mandelate salts of substituted tetracyclic tetrahydrofuran derivatives |
| 02/16/2005 | CN1582280A 3, 4-di-substituted pyridazinediones as CXC chemokine receptor antagonists |
| 02/16/2005 | CN1582279A Peroxisome proliferator activated receptor agonists |
| 02/16/2005 | CN1582276A Phenylalanine enamide derivatives |
| 02/16/2005 | CN1582274A Inhibitors of factor Xa and other serine proteases involved in the coagulation cascade |
| 02/16/2005 | CN1582271A Inhibitors of integrin alpha v beta 6 |
| 02/16/2005 | CN1582269A Hydroxyeicosenoic acid analogs |
| 02/16/2005 | CN1582168A Combinations of sterol absorption inhibitor(s) with cardiovascular agent(s) for the treatment of vascular conditions |
| 02/16/2005 | CN1582166A Vitronectin receptor antagonist pharmaceuticals for use in combination therapy |
| 02/16/2005 | CN1582154A Method for treating or prophylaxis of aldo sterone-medicated phthogenic effects in subjwect using epoxy-steroidal aldosterone antagonist |
| 02/16/2005 | CN1582152A composition of estrogen and other hormons with ascorbate, lysine, proline and other substances |
| 02/16/2005 | CN1582151A Benzothiazepine and benzothiazepine derivatives with ileal bile acid transport (IBAT) inhibitory activity for the treatment hyperlipidaemia |
| 02/16/2005 | CN1582149A Dipeptidyl peptidase IV inhibitors and their uses for lowering blood pressure levels |
| 02/16/2005 | CN1582148A Derivatives of phenoxy-n-'4-(isothiazolidin-1, 1-dioxid-2yl)pheny!-valerian- acid amide and other compounds as inhibitors of the coagulation factor Xa in the treatment of thromboembolic diseases and tu |
| 02/16/2005 | CN1582147A Derivatives of tryptamine and analogous compounds, and pharmaceutical formulations containing them |
| 02/16/2005 | CN1582116A 油组合物 Oil composition |
| 02/16/2005 | CN1580262A Carrier system containing artificial transcription factor regulated by oxygen deficit, and its configuration and use |
| 02/16/2005 | CN1580226A Medicinal liquor and its preparing method |
| 02/16/2005 | CN1580049A Method for extracting total phenyl phthalein of ligusitcum wallichii |
| 02/16/2005 | CN1579554A Gene-carrying micro-bublle of target transfergene, its preparation method and use |
| 02/16/2005 | CN1579543A Injection cerebrogalactoside carnosine and its preparing process |
| 02/16/2005 | CN1579539A Thymic hormone beta 15 to promote wound healing and generation of blood |
| 02/16/2005 | CN1579538A Garlic protein zymolysis serial product and its preparation method and use |
| 02/16/2005 | CN1579520A Preparation for eliminating thrombus and promoting lactation, and its preparation method |
| 02/16/2005 | CN1579519A Traditional Chinese medicine for treating headache disease |
| 02/16/2005 | CN1579517A Quick-acting medicated liquor for treating traumatic injury |
| 02/16/2005 | CN1579510A Traditional Chinese medicine for treating encephalatrophy and cerebral hemiplegia |
| 02/16/2005 | CN1579503A Dispersible tablet of Radix Acanthopanacis for prowoting blood-circulation and its preparation method |
| 02/16/2005 | CN1579499A Medicine for treating piles |
| 02/16/2005 | CN1579495A Preparation of traditional Chinese medicine for treating cardio vascular disease, its preparation method and quality control method |
| 02/16/2005 | CN1579493A Medicine for treating piles and its preparation method |
| 02/16/2005 | CN1579487A Medicinal composition for treating coronary heart disease |
| 02/16/2005 | CN1579471A Bizhengkang-treating arthromyodynia |
| 02/16/2005 | CN1579466A Medicine for treating cerebral infarction and preparation method |